Avicanna (TSE:AVCN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Avicanna Inc., a biopharmaceutical firm specializing in cannabinoid-based products, has confirmed its virtual Annual General Meeting (AGM) for July 10, 2024, following an extension granted by the Toronto Stock Exchange. The company has experienced significant expansion, including a new business unit and increased Canadian workforce, which contributed to the delay of the AGM. Avicanna continues to grow its international presence with a diverse medical cannabis formulary, a patient-oriented care platform, pharmaceutical products in various development stages, and a supply of active pharmaceutical ingredients.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.